Low vs standard dose valganciclovir
All‐cause death · solid organ transplant recipients
Low showed no clear difference in all‐cause death compared with standard dose valganciclovir (low certainty).
1 finding from 1 review
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients 2024 · Cochrane Headline outcomes onlyRR 0.2 [0.11, 4.11]1 study · 196 participantsLow